Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Licht

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Nature|December 2, 2008
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsThomas Thum, Carina Gross, Jan Fiedler, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Nature Medicine|June 12, 2012
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemiaAlex Kentsis, Casie Reed, Kim L Rice, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2026
Selective Glucocorticoid Receptor Modulators of Immune Checkpoint FunctionRobin R Kobylski, Charles K Min, Jerome C Nwachukwu, et al.
Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.
Cancer Research|February 9, 2026
A Multi-Step Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal MelanomaXiaonan Xu, Xiaoxian Liu, Vinesh Jarajapu, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksKartika Venugopal, Yang Feng, Pawel Nowialis, et al.
Biomaterials|December 24, 2025
Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerabilityMiao Huang, Yinong Chen, Chenyu Liang, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Nature|December 2, 2008
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsThomas Thum, Carina Gross, Jan Fiedler, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Nature Medicine|June 12, 2012
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemiaAlex Kentsis, Casie Reed, Kim L Rice, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2026
Selective Glucocorticoid Receptor Modulators of Immune Checkpoint FunctionRobin R Kobylski, Charles K Min, Jerome C Nwachukwu, et al.
Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.
Cancer Research|February 9, 2026
A Multi-Step Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal MelanomaXiaonan Xu, Xiaoxian Liu, Vinesh Jarajapu, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksKartika Venugopal, Yang Feng, Pawel Nowialis, et al.
Biomaterials|December 24, 2025
Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerabilityMiao Huang, Yinong Chen, Chenyu Liang, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Pageof 18